OPTIMA-C: Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention

Sponsor
Tan Tock Seng Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06073106
Collaborator
Rehabilitation Research Institute of Singapore (RRIS) (Other), Woodlands Health (WH) (Other)
500
1
37
13.5

Study Details

Study Description

Brief Summary

The aging population and its accompanying burden from non-communicable chronic diseases predicts an increasing impact imposed by frailty on healthcare systems. This is due to a lack of normative data for older adults and reliable risk stratification methods to develop effective approaches to the prevention of frailty.

In this study, the investigators plan to form a common dataset for phenotype identification, risk stratification of frailty and its targeted treatment plans in the at-risk and mildly frail population.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Osteosarcopaenia and multimorbidity have emerged as two key antecedent factors driving the cycle of frailty, leading to adverse outcomes. However, it remains unclear how multimorbidity and/or osteosarcopaenia act singly or in concert to influence the expression and trajectory of the frailty continuum.

    OPTIMA-C will develop unifying administrative and data platforms, exploring the feasibility of inclusive screening for sarcopaenia early during rehabilitation hospital stay. Early muscle ultrasound will also be utilised to determine key muscles possibly predictive of rehabilitation functional or global outcomes in the studied populations and their correlation with acute disease outcomes. Digital markers are quantified and correlations are investigated with physical, muscle and bone imaging findings.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention Through Identification and Deep Phenotyping Methods in Healthy Aging and High-burden Disease Cohorts.
    Anticipated Study Start Date :
    Dec 1, 2023
    Anticipated Primary Completion Date :
    Jan 1, 2027
    Anticipated Study Completion Date :
    Jan 1, 2027

    Arms and Interventions

    Arm Intervention/Treatment
    Stroke

    Both acutely admitted stroke patients undergoing rehabilitation and chronic recovered stroke outpatients will be recruited.

    Traumatic Brain Injury

    Both acutely admitted TBI patients undergoing rehabilitation and chronic recovered TBI outpatients will be recruited.

    Breast Cancer

    Only recovered breast cancer patients.

    Knee Osteoarthritis

    For patients with chronic knee osteoarthritis.

    Outcome Measures

    Primary Outcome Measures

    1. Incidence (rates) of Frailty [Through study's data collection period, up to 4 years]

      Based off different outcomes determined in the study

    2. Severity of Frailty [For inpatient: Visit 1 (within 2 weeks of admission) to Visit 6 (end of 3rd year); For outpatient: Visit 1 (baseline) to Visit 4 (end of 3rd year)]

      Based on CFS - 9-point clinical assessment tool evaluating an individual's frailty status; maximum score: 9; higher score indicates increased frailty.

    Secondary Outcome Measures

    1. Body Composition Analysis (BCA) [For inpatient: Visit 3 (6 months post-event) to Visit 6 (end of 3rd year); For outpatient: Visit 1 (baseline) to Visit 4 (end of 3rd year)]

      Measured using weak electrical current passed from feet to estimate proportion of muscle, fat and water mass.

    2. Short Physical Performance Battery (SPPB) [For inpatient: Visit 1 (within 2 weeks of admission) to Visit 6 (end of 3rd year); For outpatient: Visit 1 (baseline) to Visit 4 (end of 3rd year)]

      Measures 3 components: (1) 5 times chair stand test; (2) Balance test; (3) Gait speed (4m walk test). Score from 0-12 with higher score indicating greater functional capacity.

    3. Hand Grip Strength (kg) [For inpatient: Visit 1 (within 2 weeks of admission) to Visit 6 (end of 3rd year); For outpatient: Visit 1 (baseline) to Visit 4 (end of 3rd year)]

      Measured seated with arms on a table bent to 90° using a dynamometer (mean of 3 readings will be recorded)

    4. Muscle Ultrasound imaging [For Inpatient: Visit 1 (within 2 weeks of admission), Visit 2 (1 week pre-discharge)]

      Determines state of muscle health of arm, thigh and jaw muscles through size, area and structural properties.

    5. FRAIL Questionnaire [For inpatient: Visit 1 (within 2 weeks of admission) to Visit 6 (end of 3rd year); For outpatient: Visit 1 (baseline) to Visit 4 (end of 3rd year)]

      5-point questionnaire; (1-2 point) indicates pre-frail, (3-5 points) indicates frail

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Age ≥ 50y

    2. Asian ethnicity

    3. First diagnosis (stroke, Traumatic Brain Injury (TBI), knee osteoarthritis, breast cancer)

    4. Living in community

    5. Able to understand 1 step simple commands

    6. For inpatients: (i) within 12 weeks of disease (stroke/TBI) onset, and (ii) within 2 weeks of rehabilitation ward admission

    7. For outpatients: (i) >6 months from initial diagnosis of first stroke, TBI, knee osteoarthritis or breast cancer, and (ii) at least standby assistance, modified independent or independent in ambulation with /without walking.

    Exclusion Criteria:
    1. Nursing home or dormitory resident

    2. Non-resident status in Singapore (e.g. foreign worker, tourist, temporary visit pass)

    3. Impairments affecting understanding of questionnaires and tasks: e.g. severe deafness, severe visual impairment and severe /global aphasia,

    4. Presence of active fractures, dislocations, non-weight bearing status, burns, unhealed wounds, active skin infections/eczema and agitated behaviour or delirium

    5. Anticipated life expectancy < 1 year

    6. Presence of tracheostomy, ventilator, renal dialysis, end-organ failure

    7. Patients with disorders of consciousness.

    8. Pregnant or lactating participants

    For Knee Osteoarthritis patients only:
    1. Alternative diagnosis to knee OA e.g. Referred pain from hip or spine.

    2. Other forms of knee arthritis eg. Inflammatory, post traumatic

    3. Previous knee arthroplasty

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Tan Tock Seng Hospital Singapore Singapore 308433

    Sponsors and Collaborators

    • Tan Tock Seng Hospital
    • Rehabilitation Research Institute of Singapore (RRIS)
    • Woodlands Health (WH)

    Investigators

    • Principal Investigator: Karen Chua, Tan Tock Seng Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Tan Tock Seng Hospital
    ClinicalTrials.gov Identifier:
    NCT06073106
    Other Study ID Numbers:
    • DSRB 2023/00105
    First Posted:
    Oct 10, 2023
    Last Update Posted:
    Oct 10, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Tan Tock Seng Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 10, 2023